Javascript must be enabled to continue!
Abstract LB-90: Sox17 antagonizes Wnt/ß-catenin signaling pathway in HCC
View through CrossRef
Abstract
Background: SRY-box containing gene 17 (Sox17) is a candidate tumor suppressor gene, which is indispensable for the embryonic development by antagonizing the canonical Wnt/ß-catenin signaling pathway. We investigated the function and epigenetic regulation of Sox17 in human hepatocellular carcinoma (HCC).
Methods: Methylation and expression of Sox17 were analyzed in 62 HCC tissues and HCC cell lines by MSP and RT-PCR. Inhibitory effects of Sox17 in Wnt/ß-catenin pathway was detected by IHC and luciferase reporter assay. Function as tumor suppressor gene was tested via colony formation assay.
Results: Methylation of Sox17 promoter region occurs in 82.26% of HCC tissues and is associated with nucleus location of -catenin. Restoration of Sox17 in HepG2 cells inhibits colony formation and ß-catenin/TCF-dependent transcription with the presence of HMG box.
Conclusions: Sox17 negatively regulates canonical Wnt/ß-catenin signaling pathway, and inhibits human HCC cells growth through epigenetic mechanism.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr LB-90.
American Association for Cancer Research (AACR)
Title: Abstract LB-90: Sox17 antagonizes Wnt/ß-catenin signaling pathway in HCC
Description:
Abstract
Background: SRY-box containing gene 17 (Sox17) is a candidate tumor suppressor gene, which is indispensable for the embryonic development by antagonizing the canonical Wnt/ß-catenin signaling pathway.
We investigated the function and epigenetic regulation of Sox17 in human hepatocellular carcinoma (HCC).
Methods: Methylation and expression of Sox17 were analyzed in 62 HCC tissues and HCC cell lines by MSP and RT-PCR.
Inhibitory effects of Sox17 in Wnt/ß-catenin pathway was detected by IHC and luciferase reporter assay.
Function as tumor suppressor gene was tested via colony formation assay.
Results: Methylation of Sox17 promoter region occurs in 82.
26% of HCC tissues and is associated with nucleus location of -catenin.
Restoration of Sox17 in HepG2 cells inhibits colony formation and ß-catenin/TCF-dependent transcription with the presence of HMG box.
Conclusions: Sox17 negatively regulates canonical Wnt/ß-catenin signaling pathway, and inhibits human HCC cells growth through epigenetic mechanism.
Citation Format: {Authors}.
{Abstract title} [abstract].
In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr LB-90.
Related Results
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Bortezomib Induces Activation of b-Catenin/TCF Signaling Pathway in Multiple Myeloma
Abstract
Abstract 1851
Background:
The proteasome inhibitor Bortezomib (Bz) shows significant activity in Multipl...
Abstract 630: The role of AKT pathway in β-catenin mutated hepatocellular carcinoma
Abstract 630: The role of AKT pathway in β-catenin mutated hepatocellular carcinoma
Abstract
The Wnt/β-catenin and PI3K/AKT pathways are pivotal contributors to the development of the malignant phenotype in cancer. The activated Wnt/β-catenin pathwa...
Abstract 1584: Wnt/beta-catenin and Foxa2 axis activates AR signaling in castration resistant prostate cancer
Abstract 1584: Wnt/beta-catenin and Foxa2 axis activates AR signaling in castration resistant prostate cancer
Abstract
Background: Prostate cancer (PCa) is the leading cancer among men in the world. Androgen deprivation therapy is a common treatment to cease prostate growth....
Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent
Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent
Abstract
Carcinogenesis is often accelerated by the aberrant activation of components molecules of Wnt signaling pathway, especially, APC and beta-catenin are freque...
Abstract 3820: Wnt signaling and telomerase activation in hepatoblastoma.
Abstract 3820: Wnt signaling and telomerase activation in hepatoblastoma.
Abstract
Purpose: The abnormal Wnt/β-catenin signaling plays a key role in hepatoblastoma (HBL) development. In HBL, CTNNB1 coding ß-catenin protein with mutated or ...
Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway
Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway
Abstract
Background
Neuroinflammatory pathways are emerging therapeutic targets for neurological conditions such as Parkinson’s...
WNT-mediated regulation of regeneration and oncogenesis
WNT-mediated regulation of regeneration and oncogenesis
WNT signaling is a key cell-cell communication pathway that regulates essential cellular processes such as cell fate determination and proliferation. Accordingly, WNT signaling pla...
Abstract 209: Identification of β-catenin lysine 394 as a novel charge button and ubiquitination site by Rad6B
Abstract 209: Identification of β-catenin lysine 394 as a novel charge button and ubiquitination site by Rad6B
Abstract
Clinical evidence suggests that β-catenin accumulation in breast cancer is associated with poor prognosis. Accumulation of β-catenin occurs even though acti...

